- On 15 July 2026, Retrieve Medical Holdings, Inc. announced a partnership to integrate CLEAR’s CLEAR1 secure identity platform into its Retrieve Medical Passport ecosystem, aiming to strengthen identity verification, security, and user experience for accessing healthcare records.
- This move highlights how CLEAR’s identity technology can extend beyond travel into healthcare data access, potentially broadening use cases for its platform.
- Next, we’ll examine how CLEAR1’s integration into Retrieve Medical’s Passport ecosystem might influence Clear Secure’s investment narrative and growth focus.
Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
Clear Secure Investment Narrative Recap
To own Clear Secure, you need to believe its identity platform can keep scaling across travel and newer verticals like healthcare while management executes through leadership changes and seasonal membership swings. The Retrieve Medical partnership supports the CLEAR1 catalyst around non travel use cases, but does not obviously change the near term focus on airport automation, TSA PreCheck enrollments, and pricing, nor the key risk around execution and renewal volatility.
The Retrieve Medical Passport integration lines up closely with CLEAR’s recent healthcare push, including its February 2026 collaboration with Mount Sinai to power interoperable identity for patient access. Together, these announcements frame CLEAR1 as a healthcare grade identity solution rather than just a travel convenience, potentially reinforcing the long term thesis that identity verification across industries can complement airport growth and help diversify the business mix.
Yet even with these partnerships gaining traction, investors should still be aware of how leadership transition risk could affect...
Read the full narrative on Clear Secure (it's free!)
Clear Secure's narrative projects $1.5 billion revenue and $310.2 million earnings by 2029. This requires 16.2% yearly revenue growth and about a $187.6 million earnings increase from $122.6 million today.
Uncover how Clear Secure's forecasts yield a $62.00 fair value, a 19% upside to its current price.
Exploring Other Perspectives
Some of the lowest analysts were already cautious, assuming around US$1.4 billion of revenue and US$271.6 million of earnings by 2029, and this healthcare identity deal may push you to reconsider whether those more pessimistic views on regulatory and privacy costs still fit your own expectations.
Explore 4 other fair value estimates on Clear Secure - why the stock might be worth just $61.60!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Clear Secure research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Clear Secure research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Clear Secure's overall financial health at a glance.
Interested In Other Possibilities?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
- Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com